Guiding ABOPM's Mission
The physician leaders shaping ABOPM's clinical, operational, and scientific direction — combining decades of practice, research, and educational leadership to advance precision medicine worldwide.
Elliot Dinetz, MD
Dr. Elliot Dinetz is a board-certified Family Physician and Fellowship-trained specialist in Metabolic and Functional Medicine. Early in his career, he recognized that the central challenge facing healthcare is not merely a lack of access, but a culture that overlooks root causes.
Read More
Committed to changing this paradigm, Dr. Dinetz employs preventive and restorative Functional Medicine. As an early adopter of Clinical Genomics and precision medicine, he utilizes advanced biomarkers to identify and correct imbalances, extending healthspan and reversing disease trajectories that conventional medicine accepts as inevitable.
His innovative approach has led to numerous publications in peer-reviewed medical journals and popular magazines. His expertise has earned him invitations to speak at national and international medical conferences, promoting advanced methodologies and aiding physicians in transforming medicine for the better.
Dr. Dinetz serves on the advisory boards of the Age Management Medical Group (AMMG), Forbes Health, and the Institute for Regenerative and Cellular Medicine. He has contributed to prominent publications including Psychology Today and TIME Magazine. He is a Voluntary Assistant Professor in the Department of Family Medicine at the University of Miami Miller School of Medicine, and is the founder of Timeless Health in Miami, FL.
Emre Baser, MD
Leading at the intersection of precision medicine, oncology, molecular pathology, and diagnostics — empowering patients and colleagues through innovation, knowledge-sharing, and a commitment to patient-centered care.
Read More
Dr. Emre Baser leads initiatives at the intersection of precision medicine, oncology, molecular pathology, and diagnostics. Trained in medicine at Cumhuriyet University (Türkiye) and Maastricht University (Netherlands), with clinical experience at Justus Liebig University (Germany), he brings both deep clinical expertise and a passionate research vision to his leadership role at ABOPM.
Dr. Baser has spearheaded pioneering research projects in collaboration with academic institutions, research foundations, and pharmaceutical companies, while simultaneously leading educational initiatives in precision oncology. His work bridges translational cancer science and frontline clinical application.
Dedicated to both innovation and patient-centered education, Dr. Baser empowers patients and colleagues through knowledge-sharing and mentorship. Beyond medicine, he values time with family and is an avid reader who draws on diverse perspectives to enrich his clinical and scientific work.
Puya Yazdi, MD
Dr. Yazdi is a physician-scientist and entrepreneur specializing in genomics, bioinformatics, and AI-driven precision medicine innovation.
Read More
He completed medical training at USC and residency at Stanford University and later became a Clinical Fellow in regenerative medicine at UC Irvine.
As founder of Systomic Health and leader at SelfDecode, he has pioneered genomic technologies used by biotechnology companies and global health platforms.
His work focuses on translating advanced genomic science into scalable healthcare solutions worldwide.
Ralph Kenney
Ralph Kenney is a senior executive specializing in health technology, strategic growth, and AI-driven precision health platforms.
Read More
As COO and CFO of SelfDecode he built a B2B division generating over $100M in contracts and helped expand the company's genomics platform worldwide.
Previously he served as COO of R Systems Inc., scaling operations dramatically and leading the company through a successful IPO.
Earlier leadership roles at AT&T involved managing business units with more than $150M in annual revenue.
Marc Kielburger
A New York Times bestselling author, Harvard graduate, Rhodes Scholar, and Oxford-trained lawyer, Marc is a trailblazing movement builder who has collaborated with leaders like Oprah Winfrey and brands like Virgin Group.
Read More
He has headlined more than 130 live stadium events, inspiring millions, and has received ten honorary degrees. He is the cohost of the award-winning My Legacy podcast and the cofounder of Unlimited Life, an organization dedicated to helping people live their longest, healthiest, best lives.
A certified reiki master and certified health coach, Marc brings a holistic, purpose-driven approach to wellbeing, leadership, and transformation.
Arzu Özcan, MD, MBA
Dr. Özcan is an accomplished medical affairs leader with 15+ years of experience across oncology, immunology, neuroscience, cardiovascular, and diagnostics.
Read More
She has held senior medical affairs roles at Edwards Lifesciences, Daiichi Sankyo, Kite Pharma, Teva Pharmaceuticals, and Sandoz Pharmaceuticals — leading initiatives spanning KOL engagement, advisory boards, evidence generation planning, Investigator Sponsored Trials, Clinical Evidence Plans, and regulatory-aligned scientific communications across global portfolios.
Dr. Özcan holds an MD from Ondokuz Mayıs University and an MBA from DeVry University, with continuing education in Immunology from Harvard Medical School. Fluent in English and Turkish, she is culturally agile across US and global teams.
The Role of Multi-Omics in Precision Medicine
Modern medicine increasingly recognizes that disease is driven by complex biological interactions rather than single genetic or molecular abnormalities. Multi-omics science integrates multiple biological layers to provide a comprehensive molecular understanding of health and disease.
Genomics – The study of DNA and genetic variation that influences disease risk and treatment response.
Transcriptomics – Analysis of gene expression patterns that reveal how cells respond to disease processes.
Proteomics – Investigation of protein structures and interactions that drive biological function.
Metabolomics – Measurement of metabolic pathways that reflect cellular activity and disease states.
Microbiomics – Understanding the role of the human microbiome in immune regulation, metabolism, and chronic disease.
Insights Shaping
Precision Medicine
Explore ABOPM perspectives on genomics, multi-omics, systems thinking, clinical innovation, and the future of physician leadership in precision medicine.
Biomarkers in Autoimmune Disease: Toward Personalized Immunology
Discover how biomarkers are advancing precision immunology by improving the diagnosis, prognosis, and personalized treatment of autoimmune diseases such as rheumatoid arthritis, lupus, and inflammator... ...more
Precision Medicine in Action
August 06, 2026•8 min read
Immunotherapy and Precision Medicine: Personalizing the Immune Response
Discover how precision medicine is transforming immunotherapy through biomarkers like PD-L1, TMB, and MSI-helping clinicians identify the right patients for the right cancer treatments. ...more
Precision Oncology
July 31, 2026•8 min read
Precision Public Health: Applying Genomics at the Population Level
Explore how precision public health integrates genomics, epidemiology, and data science to improve disease prevention, population health, and personalized public health strategies. ...more
Population Precision
July 24, 2026•9 min read
Stay at the Forefront of Precision Medicine
Subscribe to receive ABOPM insights, research updates, and educational resources delivered directly to your inbox.
Advancing education, certification, and leadership to shape a genomics-driven, data-intelligent future of healthcare.
COMPANY
RESOURCES
© 2023-2025 American Board of Precision Medicine, Inc. All Rights Reserved.